Brief: EC Formally Authorises COVID-19 Drugs From Regeneron-Roche, Celltrion
Nov 12 (Reuters) - European Medicines Agency (EMA):
* EMA: THE EUROPEAN COMMISSION AUTHORISED THE COVID-19
TREATMENTS
REGKIRONA (REGDANVIMAB) AND RONAPREVE (CASIRIVIMAB / IMDEVIMAB),
FOLLOWING EVALUATION BY EMA: 12/11/2021
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Celltrion Healthcare Co
See all newsBrief: Celltrion USA says Ventegra Will Place FDA-Approved Biosimilar To Avastin , Vegzelma On Its Commercial Formulary As A Preferred Brand
Brief: Celltrion Healthcare To Acquire 92.7 Billion Won Worth Of Own Shares
Brief: Celltrion Healthcare Q3 Operating Profit 50.5 Billion Won, Down 30.4% From Year Earlier
Brief: Celltrion Usa- Announces Distribution And Incorporation Of Yuflyma (Adalimumab-Aaty) To Carepartners Specialty Pharmacy Cost Savings Programs
Brief: Celltrion Healthcare's Merger With Celltrion Approved In Shareholder Meeting -Yonhap